ARMATA PHARMACEUTICALS INC has a total of 23 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2012. It filed its patents most often in EPO (European Patent Office), Australia and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and medical technology are G L PHARMA GMBH, ONXEO and ORBIS HEALTH SOLUTIONS LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 5 | |
#2 | Australia | 4 | |
#3 | Canada | 4 | |
#4 | United States | 4 | |
#5 | Israel | 3 | |
#6 | WIPO (World Intellectual Property Organization) | 2 | |
#7 | China | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Medical technology | |
#4 | Basic materials chemistry | |
#5 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Morales Sandra P | 14 |
#2 | Mearns Gillian | 11 |
#3 | Rankin Deborah A | 11 |
#4 | Smrekar Frenk | 5 |
#5 | Shaw Karen Joy | 5 |
#6 | Smremar Frenk | 3 |
#7 | Bilinsky Igor P | 3 |
#8 | Morales Sandra | 2 |
#9 | Harper David | 2 |
#10 | Blake Katy | 2 |
Publication | Filing date | Title |
---|---|---|
WO2020072823A1 | Bacteriophage treatment and reduction in inflammatory response | |
WO2019157231A2 | Bacteriophage for treatment and prevention of bacteria-associated cancers | |
CN110719784A | Therapeutic phage compositions | |
US2017065649A1 | Therapeutic bacteriophage compositions |